BIOCQ — Biocept Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$4.46m
- $25.86m
Biocept Inc falls after Q4 loss
Biocept Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Biocept Appoints Samuel D. Riccitelli As Interim President And Chief Executive Officer And Antonino Morales As Interim Chief Financial Officer
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:13 PM
Brief: Biocept Determines Co's Interim Financial Statements Can No Longer Be Relied Upon - SEC Filing
Brief: Biocept Reports An Increase In Covid-19 Rt-Pcr Testing Volume With Spread Of The Omicron Variant
Brief: Biocept’s CNside Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations In Patients With Breast Cancer That Has Metastasized To The Brain
Brief: Biocept Launches Combined COVID-19, Influenza Test
Biocept down on delay in commercialization of COVID-19 test
Biocept Inc reports results for the quarter ended in September - Earnings Summary
Brief: Biocept Q3 Revenue Up 165% To $17.5 Mln
Biocept Inc expected to post earnings of 7 cents a share - Earnings Preview
Brief: Study Shows Biocept's Technology Improves Rare Cancer Mutations Detection Assays
Biocept Inc expected to post earnings of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Robinhood, Ford, Macy's
Biocept jumps as test detects tumor cells in lung cancer patients
Brief: Biocept’S Cnside Assay Identifies Tumor Cells And Actionable Treatment Biomarkers In Patients With Non-Small Cell Lung Cancer
Biocept Inc reports results for the quarter ended in June - Earnings Summary
Brief: Biocept Reports Second Quarter 2021 Financial Results